thieme · synthesis of amino urea catalysts representative procedure for the preparation of amino...
Post on 05-Aug-2019
216 Views
Preview:
TRANSCRIPT
Thieme
Supporting Information for DOI: 10.1055/s-0037-1611860
© 2019. Thieme. All rights reserved.Georg Thieme Verlag KG, Rüdigerstraße 14, 70469 Stuttgart, Germany
1
Catalytic Asymmetric Intramolecular Bromolactonization of
α,β-Unsaturated Ketones
Shenghui Liu,a Hailong He,
b Min Gan,
a Peng Yi,
a Xiaojian Jiang*
a
* chemjxj2015@jnu.edu.cn
Table of Contents
GENERAL METHODS
General procedures -------------------------------------------------------------------------------------------------------- 2
Materials -------------------------------------------------------------------------------------------------------------------- 2
Instrumentation ------------------------------------------------------------------------------------------------------------ 2
SYNTHESIS OF AMINO UREA CATALYSTS
Representative Procedure for the Preparation of Amino Urea Catalyst -------------------------------------------- 3
SYNTHESIS OF α, β-UNSATURATED ACID SUBSTRATES
Representative Procedure for the Preparation of α, β-Unsaturated Ketone -------------------------------------------- 9
SYNTHESIS OF BROMOLACTONE PRODUCTS
General Procedure for Bromolactonization --------------------------------------------------------------------------- 14
Synthetic Application ---------------------------------------------------------------------------------------------------- 27
X-ray of 4b----------------------------------------------------------------------------------------------------------------- 29
References ----------------------------------------------------------------------------------------------------------------- 30
1H/
13C Spectra ------------------------------------------------------------------------------------------------------------ 31
a International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug
Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou
510632, China
b Guangzhou Wanglaoji Pharmaceutical Company Limited, Guangzhou 510450, China
2
GENERAL METHODS
General Procedures
All reactions were generally performed open air or in dried glassware under an atmosphere of dry N2.
Reaction mixtures were stirred magnetically unless otherwise indicated and monitored by thin layer
chromatography (TLC) on Merck precoated glass-backed silica gel 60 F-254 0.25 mm plates with
visualization by fluorescence quenching at 254 nm. TLC plates were stained using potassium permanganate.
Chromatography purification of products (flash column chromatography) was performed on silica gel 60
(70−230 mesh, Merck) using a forced flow of eluent at 0.3−0.5 bar. Concentration of reaction product
solutions and chromatography fractions under reduced pressure was performed by rotary evaporation at
35−45oC at the appropriate pressure and then at rt, ca. 10 mmHg (vacuum pump) unless otherwise indicated.
Materials
All chemicals, including dry solvents were purchased from Aldrich, Fluka, Acros, TCI, Merck, Strem, or
Alfa Aesar and used as such unless stated otherwise. Yields given refer to chromatographically purified
compounds unless otherwise demonstrated.
Instrumentation
Melting points were determined on a Sinoinstructment melting point apparatus. 1H NMR spectra was
recorded on Bruker 300 MHz or Bruker 400 MHz spectrometer. 13
C NMR spectra was recorded on Bruker
75 MHz or Bruker 100 MHz spectrometer. 13
C NMR chemical shifts are expressed in parts per million ()
downfield from tetramethylsilane (with the central peak of CHCl3 at 77.16 ppm used as standard). 1H NMR
chemical shifts are expressed in parts per million () downfield from tetramethylsilane (with the peak of
CHCl3 at 7.26 ppm used as standard; with the peak of benzene at 7. 36 ppm used as standard). All 13
C
spectra were measured with complete proton decoupling. NMR coupling constants (J) are reported in Hertz
(Hz), and splitting patterns are indicated as follows: br, broad; s, singlet; d, doublet; dd, doublet of doublet;
ddd, doublet of doublet of doublet; dt, doublet of triplet; t, triplet; q, quartet; m, multiplet. High resolution
mass spectrometric measurements (HRMS) were performed by the AB SCIEX, Triple TOF 5600+.
Enantiomeric excesses were determined by HPLC analysis on Shimadzu HPLC units, including the
following instruments: pump, LC-16; detector, SPD-16; column, Daicel Chiralpak AD-H.
3
SYNTHESIS OF AMINO UREA CATALYSTS
Representative Procedure for the Preparation of Amino Urea Catalyst1
To a solution of A (1.0 mmol, 1.0 eq) in THF (5 mL) was added phenyl isocyanate (1.0 mmol, 1.0 eq) in one
portion at room temperature. The reaction was stirred for 16 h. After evaporation of THF, the residue was
purified by flash column chromatography (MeOH/EtOAc 1:10) to afford amino urea catalyst 5a 384.5 mg,
87% yield; pale yellow solid; MP 136-137°C; []
D25= 35.0 (c 1.0, MeOH); exist as rotamers, and the main
signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.71 – 8.73 (m, 1H), 8.00 – 8.05 (m, 2H), 7.76
(s, 1H), 7.28 – 7.40 (m, 4H), 7.17 – 7.22 (m, 2H), 6.94 – 6.99 (m, 1H), 6.81 – 6.83 (m, 1H), 5.58 – 5.70 (m,
1H), 5.55 (s, broad, 1H), 3.99 – 4.02 (m, 4H), 3.37 – 3.56(m, 2H), 3.08 – 3.16 (m, 1H), 2.65 – 2.73 (m, 2H),
2.28 – 2.35 (m, 2H), 1.52 – 1.73 (m, 4H), 0.92 – 0.98 (m, 1H). 13
C NMR (101 MHz, CDCl3) δ 158.22,
155.50, 147.53, 144.76, 144.41, 139.56, 139.15, 131.64, 128.91, 128.29, 122.77, 122.12, 119.43, 115.67,
101.87, 59.73, 55.83, 55.07, 41.19, 38.35, 27.07, 26.58, 25.84; HRMS (TOF+) calcd. for C27H31N4O2
[M+H]+ 443.2442, found 443.2421.
375.7 mg, 85% yield; pale yellow solid; MP 134-136°C; []
D25= –68.5 (c 1.0, MeOH); exist as rotamers, and the
main signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.80 – 8.66 (m, 2H), 7.90 – 7.63 (m,
3H),7.45 (d, J = 2 Hz, 2H), 7.32 – 7.12 (m, 3H), 6.92 – 6.89 (m, 1H), 5.90 – 5.85 (m, 1H), 5.76 – 5.68 (m,
1H), 5.09 – 5.05 (m, 2H), 4.65 – 4.32(m, 2H), 3.99 (s, 3H), 3.57 – 3.13(m, 3H), 2.49 (s, broad, 1H), 1.98 –
1.80 (m, 3H), 1.03 – 1.00 (m, 1H). 13
C NMR (75 MHz, CDCl3) δ 158.53, 155.43, 147.69, 144.61, 142.64,
139.48, 137.16, 131.49, 128.81, 128.08, 122.56, 122.36, 118.94, 117.04, 101.38, 59.90, 55.83, 49.11, 45.85,
36.73, 26.53, 24.79, 23.95; HRMS (TOF+) calcd. for C27H31N4O2 [M+H]
+ 443.2442, found 443.2423.
4
358 mg, 87%, white solid; MP 117-119°C; []
D25= 114.1 (c 1.0, MeOH); exist as rotamers, and the main signals
were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.85 (d, J = 6 Hz, 1H), 8.39 – 8.42 (m, 1H), 8.14 (d, J =
6 Hz, 1H), 8.06 (s, 1H), 7.59– 7.75 (m, 2H), 7.33 – 7.47 (m, 2H), 7.27 – 7.33 (m, 1H), 7.17 – 7.23 (m, 5H),
6.94 – 6.99 (m, 2H), 5.80 – 5.91 (m, 1H), 5.54 (s, broad, 1 H), 5.15 – 5.23 (m, 2H), 4.00 (s, broad, 1H), 2.71
– 3.24 (m, 5H), 2.24 – 2.36 (m, 1H), 1.65 (s, 1H), 1.23-1.25 (m, 1H), 0.90 – 0.99 (m, 1H). 13
C NMR (75
MHz, CDCl3) δ 155.70, 150.17, 148.51, 139.19, 139.04, 130.31, 129.46, 129.36, 128.90, 126.99, 123.38,
122.72, 119.44, 115.76, 48.92, 46.64, 38.44, 27.04, 25.62, 24.90; HRMS (TOF+) calcd. for C26H29N4O
[M+H]+ 413.5793, found 413.5791.
375.7 mg, 85% yield; pale yellow solid; MP 132-134°C; []
D25= 52.5 (c 1.0, MeOH); exist as rotamers, and the
main signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.84 – 8.85(m, 1H), 8.37 (d, J = 9 Hz, 1H),
8.00 – 8.29 (m, 2H),7.42 – 7.73 (m, 4H), 7.21– 7.24 (m, 2H), 6.72 – 6.75 (m, 2H), 5.66 – 6.06 (m, 4H), 5.19
– 5.26 (m, 2H), 3.71 (s, 3H), 3.47 – 3.50 (m, 1H), 3.22 – 3.29 (m, 1H), 3.04 – 3.08 (m, 1H), 2.77 – 2.93 (m,
2H), 2.32 – 2.35 (m, 1 H), 2.01 (s, 1H), 1.54 – 1.68 (m, 3H), 1.24 – 1.31 (m, 1H), 0.98 – 1.07 (m, 1H). 13
C
NMR (75 MHz, CDCl3) δ 155.95, 155.50, 150.24, 148.41, 146.29, 138.17, 132.25, 130.22, 129.47, 127.18,
127.03, 123.38, 121.65, 116.37, 114.12, 60.22, 55.47, 48.78, 46.16, 37.68, 26.78, 24.84, 24.66; HRMS
(TOF+) calcd. for C27H31N4O2 [M+H]
+ 443.2442, found 443.2420.
392.2 mg, 86% yield; pale yellow solid; MP 139-141°C; []
D25= 67.0 (c 1.0, MeOH); exist as rotamers, and the
main signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.81 – 8.83 (m, 1H), 8.35 – 8.38 (m, 2H),
8.05 – 8.08 (m, 1H), 7.52 – 7.69 (m, 3H), 7.19 – 7.22 (m, 2H), 6.70 (d, J = 9 Hz, 1H), 5.67 – 5.83 (m, 2H),
5.34 – 5.44 (m, 3H), 5.15 – 5.21 (m, 2H), 3.84 – 3.91 (m, 2H), 3.44 – 3.54 (m, 1H), 3.30 (s, 1H), 2.74 – 3.30
(m, 4H)), 2.28 – 2.36 (m, 1H),1.97 (s, 1H), 1.50 – 1.62 (m, 3H), 1.29 – 1.33 (m, 3H), 0.97 – 1.24 (m, 3H).
13C NMR (75 MHz, CDCl3) δ 155.97, 154.69, 150.26, 148.30, 138.29, 132.28, 130.08, 129.45, 127.15,
123.43, 121.40, 116.22, 114.75, 63.65, 60.17, 48.83, 46.24, 45.50, 37.69, 26.79, 24.83, 14.83, 9.02; HRMS
(TOF+) calcd. for C28H33N4O2 [M+H]
+ 457.3726, found 457.3725.
5
375.7 mg, 85% yield; pale yellow solid; MP 144-146°C; []
D25= 92.5 (c 1.0, MeOH); exist as rotamers, and the
main signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.82 (d, J = 6 Hz, 1H), 8.42 (s, 1H), 8.30 (d,
J = 9 Hz, 1H), 8.01 (d, J = 9 Hz, 1H), 7.54– 7.66 (m, 3H), 7.42– 7.44 (m, 1H), 7.03 (s, 1H), 6.75 – 6.78 (m,
1H), 6.53 – 6.59 (m, 3H), 5.66 – 5.77 (m, 2H), 5.16 – 5.22 (m, 2H), 3.74 – 3.78 (m, 1H), 3.68 (s, 6H), 3.44
(s, 1H)), 3.20 (s, 1H), 2.95 – 3.01 (m, 1H), 2.79 – 2.81 (m, 1H), 2.24 – 2.38 (m, 1H), 1.88 (s, 1H), 1.51 –
1.63 (m, 3H), 1.02 – 1.24 (m, 3H). 13
C NMR (75 MHz, CDCl3) δ 155.63, 150.38, 148.96, 148.27, 145.38,
144.66, 137.46, 132.97, 130.12, 129.55, 127.32, 126.86, 123.27, 116.74, 111.57, 104.77, 60.34, 56.11, 55.87,
48.90, 46.05, 41.70, 37.09, 26.59, 24.36, 24.15, 21.00, 14.15, 11.60, 11.07; HRMS (TOF+) calcd. for
C28H33N4O3 [M+H]+ 473.6011, found 473.6012.
425.0 mg, 85% yield; pale yellow solid; MP 150-151°C; []
D25= 49.0 (c 1.0, MeOH); exist as rotamers, and the
main signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.90 (d, J = 3 Hz, 1H), 8.33 – 8.47 (m, 2H),
8.06(d, J = 9 Hz, 1H), 8.01 (d, J = 9 Hz, 1H), 7.59 – 7.75 (m, 3H), 7.41 – 7.44 (m, 1H), 7.09 – 7.13 (m, 1H),
6.81 – 6.85 (m, 1H), 6.63 – 6.66 (m, 1H), 5.70 – 5.99 (m, 2H), 5.25– 5.36 (m, 5H), 3.88 – 4.00(m, 5H), 3.58
– 3.64 (m, 1H), 3.18 – 3.42 (m, 2H)), 2.97 – 3.07 (m, 1H), 2.40 – 2.52 (m, 1H), 1.30 – 1.34 (m, 6H), 1.20 –
1.26 (m, 2H). 13
C NMR (75 MHz, CDCl3) δ 155.56, 150.51, 149.07, 148.33, 144.63, 144.23, 137.00, 133.25,
130.17, 129.63, 127.47, 126.81, 123.27, 119.69, 117.16, 114.54, 111.65, 106.53, 65.12, 64.61, 60.39, 49.11,
46.04, 36.75, 26.54, 24.34, 23.79, 14.89, 14.78; HRMS (TOF+) calcd. for C30H37N4O3 [M+H]
+ 501.7148,
found 501.7149.
378.5 mg, 83% yield; pale yellow solid; MP 129-131°C; []
D25= 81.5.0 (c 1.0, MeOH); exist as rotamers, and the
main signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.85 (d, J = 6 Hz, 1H), 8.51 (s, 1H), 8.31 (d,
6
J = 6 Hz, 1H), 8.02 – 8.05 (m, 1H), 7.56 – 7.73 (m, 3H), 7.41 – 7.44 (m, 1H), 7.07 (s, 1H), 6.85 (s, broad,
1H), 6.66 – 6.69 (m, 1H), 6.52 – 6.55 (m, 1H), 5.68 – 5.89 (m, 4H), 5.22 – 5.30 (m, 2H), 4.00 – 4.08 (s, 1H),
3.63 (s, 1H), 3.62 (s, 1H), 2.83 – 2.98 (m, 3H)), 2.45 – 2.47 (m, 1H), 1.99 (s, 1H), 1.86 (s, 1H), 1.65 – 1.73
(m, 3H), 1.18 – 1.30 (m, 5H). 13
C NMR (75 MHz, CDCl3) δ 178.48, 171.15, 155.60, 150.43, 148.31, 147.51,
144.60, 142.83, 137.04, 133.72, 130.12, 129.63, 127.50, 126.82, 123.24, 117.08, 112.28, 107.90, 102.29,
100.86, 60.36, 60.29, 49.07, 45.92, 41.88, 36.72, 26.55, 24.36, 23.83, 21.02, 14.16, 11.11; HRMS (TOF+)
calcd. for C27H29N4O3 [M+H]+ 457.6172, found 457.6171.
385.4 mg, 82% yield; pale yellow solid; MP 137-139°C; []
D25= 102.5.0 (c 1.0, MeOH); exist as rotamers, and
the main signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.88 (d, J = 3 Hz, 1H), 8.33 – 8.49 (m,
2H), 8.05 – 8.08 (m, 1H), 7.46 – 7.71 (m, 4H), 7.02 (s, 1H), 6.86 – 6.88 (m, 1H), 6.57 (s, broad, 3H), 5.71 –
6.01 (m, 2H), 5.25 – 5.38 (m, 2H), 3.96 – 4.13 (m, 5H), 3.62 – 3.69 (m, 1H), 3.25 – 3.40 (m, 2H), 2.87 –
2.89 (m, 1H), 2.49 – 2.51 (m, 1H), 2.20 (s, 1H), 1.90 (s, 1H), 1.66 – 1.76 (m, 3H), 1.21 – 1.34 (m, 3H). 13
C
NMR (75 MHz, CDCl3) δ 155.53, 150.69, 148.39, 144.50, 143.31, 139.04, 137.00, 133.24, 130.19, 129.61,
127.49, 126.84, 123.28, 119.62, 117.18, 116.96, 113.03, 108.90, 64.38, 64.19, 60.32, 49.08, 45,89, 41,87,
36.67, 26.58, 24.39, 23.81, 14.18, 11.15; HRMS (TOF+) calcd. for C28H31N4O3 [M+H]
+ 471.3940, found
471.3941.
400.0 mg, 80% yield; pale yellow solid; MP 140-142°C; []
D25= 113.0 (c 1.0, MeOH); exist as rotamers, and the
main signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.87 (d, J = 6 Hz, 1H), 8.35 – 8.38 (m, 1H),
8.09 – 8.15 (m, 2H), 7.59 – 7.74 (m, 3H), 6.67 (s, 1H), 6.55 (s, 1H), 5.75 – 5.86 (m, 2H), 5.25 – 5.30 (m,
4H), 4.07 – 4.21 (m, 4H), 3.76 (s, 3H), 2.88 – 3.48 (m, 4H), 2.40 – 2.50 (m, 1H), 2.00 (d, J = 9 Hz, 1H),
1.64 – 1.76 (m, 3H), 1.11 – 1.37 (m, 3H). 13
C NMR (75 MHz, CDCl3) δ 155.48, 150.35, 148.78, 148.42,
145.33, 143.81, 137.46, 132.39, 130.26, 129.57, 128.86, 127.35, 126.87, 123.28, 116.92, 101.27, 97.31,
64.40, 60.34, 56.12, 48.90, 46.03, 37.21, 26.68, 24.51, 24.30, 14.18; HRMS (TOF+) calcd. for C29H33N4O4
[M+H]+ 501.7145, found 501.7146.
7
399.5 mg, 85% yield; pale yellow solid; MP 127-129°C; []
D25= 94.0 (c 1.0, MeOH); exist as rotamers, and the
main signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.86 (d, J = 3 Hz, 1H), 8.33 – 8.36 (m, 1H),
8.05 – 8.07 (m, 1H), 7.51 – 7.70 (m, 5H), 7.37 – 7.50 (m, 1H), 6.59 – 6.61 (m, 2H), 5.70 – 5.86 (m, 4H),
5.22 – 5.30 (m, 2H), 3.90 (q, J = 6 Hz, 3H), 2.78 – 3.49 (m, 4H), 2.33 – 2.47 (m, 1H), 2.10 (s, 3H), 1.61 –
1.73 (m, 3H), 1.32 (t, J = 3 Hz, 3 H), 1.20 – 1.26 (m, 2H). 13
C NMR (75 MHz, CDCl3) δ 156.42, 155.87,
150.41, 148.37, 145.14, 137.34, 132.99, 130.13, 129.58, 127.38, 126.94, 125.64, 123.44, 119.57, 116.89,
116.39, 112.07, 63.53, 60.09, 48.99, 45.85, 36.93, 26.58, 24.49, 24.11, 18.40, 14.85; HRMS (TOF+) calcd.
for C29H35N4O2 [M+H]+ 471.6349, found 471.6350.
394.8 mg, 84% yield; pale yellow solid; MP 126-128°C; []
D25= 69.5 (c 1.0, MeOH); exist as rotamers, and the
main signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.84 (d, J = 3 Hz, 1H), 8.33 – 8.36 (m, 1H),
8.05 – 8.07 (m, 1H), 7.51 – 7.69 (m,5H), 7.28 – 7.34 (m, 1H), 6.57 – 6.61 (m, 2H), 5.71 – 5.81 (m, 4H), 5.21
– 5.27 (m, 2H), 3.90 (q, J = 6 Hz, 2H), 3.52 – 3.70 (m, 1H), 2.78 – 2.24 (m, 3H), 2.28 – 2.45 (m,1H), 2.09 (s,
3H), 1.57 – 1.70 (m, 3H), 1.29 (t, J = 9 Hz, 3 H), 1.11 – 1.26 (m, 3H). 13
C NMR (75 MHz, CDCl3) δ 156.45,
155.91, 150.34, 148.34, 145.52, 137.58, 133.06, 130.11, 129.56, 127.29, 126.96, 125.70, 123.45, 119.56,
116.70, 116.40, 112.09, 63.52, 60.37, 60.02, 48.88, 45.87, 37.11, 26.62, 24.53, 24.30, 21.02, 18.32, 14.84,
14.17; HRMS (TOF+) calcd. for C29H35N4O2 [M+H]
+ 471.6347, found 471.6349.
416.2 mg, 86% yield; pale yellow solid; MP 141-143°C; []
D25= 71.0 (c 1.0, MeOH); exist as rotamers, and the
main signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.86 (d, J = 6 Hz, 1H), 8.34 – 8.37 (m, 1H),
8.04 – 8.07 (m, 1H), 7.56 – 7.70 (m, 4H), 7.22 (s, 1H), 6.50 (s, 1H), 6.23 (s, broad, 2H), 5.70 – 5.93 (m, 2H),
5.23 – 5.30 (m, 2H), 3.99 – 4.12 (m, 1H), 3.90 (q, J = 6 Hz, 2H), 2.95 – 3.59 (m, 4H), 2.34 – 2.50 (m, 1H),
2.08 – 2.11 (m, 6H), 1.89 – 1.94 (m, 1H), 1.35 – 1.48 (m, 3H), 1.32 (s, 2H), 1.30 (t, J = 6 Hz, 3 H), 1.22 –
1.25 (m, 3H). 13
C NMR (75 MHz, CDCl3) δ13
C NMR (101 MHz, CDCl3) δ 156.76, 155.81, 154.62, 151.88,
150.24, 148.49, 146.58, 145.59, 138.46, 137.84, 134.61, 130.31, 129.31, 128.62, 127.90, 127.60, 127.07,
8
126.94, 124.79, 123.48, 123.21, 119.53, 116.12, 113.56, 83.03, 63.91, 60.30, 48.87, 46.46, 38.01, 27.68,
26.95, 25.14, 24.73, 18.12, 15.80, 14.97.; HRMS (TOF+) calcd. for C30H37N4O2 [M+H]
+ 485.7133, found
485.7131.
406.6 mg, 84% yield; pale yellow solid; MP 144-145°C; []
D25= 85.5 (c 1.0, MeOH); exist as rotamers, and the
main signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.86 (d, J = 3 Hz, 1H), 8.35 – 8.37 (m, 1H),
8.07 – 8.09 (m, 1H), 7.57 – 7.72 (m, 4H), 7.32 (s, 1H), 7.10 – 7.13 (m, 1H), 6.56 – 6.59 (m, 1H), 5.74 – 5.83
(m, 1H), 5.50 (s, broad, 2H), 5.21 – 5.29 (m, 2H), 3.91 (q, J = 6 Hz, 2H), 3.29 – 3.45 (m, 2H), 2.75 – 3.00
(m, 2H), 2.31 – 2.44 (m, 1H), 2.02 – 2.08 (m, 6H), 1.61 – 1.72 (m, 3H), 1.30 (t, J = 9 Hz, 3 H), 1.22 – 1.24
(m, 3H). 13
C NMR (75 MHz, CDCl3) δ 156.87, 154.63, 150.38, 148.39, 145.53, 137.60, 133.26, 130.16,
129.51, 129.09, 127.25, 127.02, 125.90, 123.83, 123.53, 119.58, 116.71, 109.42, 64.08, 60.05, 48.95, 45.99,
41.77, 37.24, 26.71, 24.57, 24.37, 14.98, 14.58, 12.28, 11.05; HRMS (TOF+) calcd. for C30H37N4O2 [M+H]
+
485.7132, found 485.7130.
399.5 mg, 85% yield; pale yellow solid; MP 136-137°C; []
D25= 79.5 (c 1.0, MeOH); exist as rotamers, and the
main signals were assigned: 1H NMR (300 MHz, Chloroform-d) δ 8.86 (d, J = 3 Hz, 1H), 8.34 – 8.40 (m, 1H),
8.05 – 8.07 (m, 1H), 7.55 – 7.70 (m, 4H), 7.39 (s, 1H), 7.12 – 7.20 (m, 1H), 6.53 – 6.56 (m, 1H), 5.69 – 5.82
(m, 5H), 5.21 – 5.29 (m, 2H), 3.90 – 4.03 (m, 1H), 3.69 (s, 3H), 3.38 – 3.55 (m, 2H), 2.89 – 3.07 (m, 2H),
2.31 – 2.46 (m, 1H), 2.00 – 2.03 (m, 6H), 1.63 – 1.72 (m, 3H), 1.20 – 1.26 (m, 3H). 13
C NMR (75 MHz,
CDCl3) δ 156.80, 155.16, 150.43, 148.35, 145.15, 137.31, 133.16, 130.09, 129.56, 129.21, 127.34, 126.98,
125.44, 123.77, 123.53, 119.60, 116.87, 107.96, 60.02, 55.68, 49.02, 45.84, 36.94, 26.61, 24.50, 24.10,
14.55, 12.17; HRMS (TOF+) calcd. for C29H35N4O2 [M+H]
+ 471.6346, found 471.6348.
9
472.3 mg, 86% yield; pale yellow solid; MP 144-145°C; []
D25= 66.0 (c 1.0, MeOH);
1H NMR (400 MHz,
Chloroform-d) δ 9.10 (s, broad, 1H), 8.93 (d, J = 4 Hz, 1H), 8.43 – 8.19 (m, 2H), 7.82 –7.76 (m, 3H), 7.68 –
7.40 (m, 3H), 6.84 (s, broad, 1H), 5.90–5.81 (m, 1H), 5.18–5.06 (m, 2H), 3.48 (s, 1H), 2.98 – 2.62 (m, 5H),
2.26 – 2.21 (m, 1H), 1.62 – 1.27 (m, 4H), 0.95 – 0.88 (m, 1H). 13
C NMR (100 MHz, CDCl3) δ 155.2, 149.9,
148.4, 141.1, 139.5, 132.5 (q, J = 32 Hz), 130.1, 129.6, 127.1, 124.6, 123.4, 121.9, 118.0, 115.3, 48.8, 46.8,
38.8, 27.1, 26.0, 25.0; HRMS (TOF+) calcd. for C28H27F6N4O [M+H]
+ 549.4127, found 549.4129.
SYNTHESIS OF α, β-UNSATURATED ACID SUBSTRATES
Representative Procedure for the Preparation of α, β-Unsaturated Ketone1, 2
Step-1: To a solution of benzaldehyde (1.06 g, 10 mmol, 1.0 equiv) in THF (20 ml ) was added CuI (38 mg,
2 mmol , 0.2 equiv) at -20 °C under nitrogen. After stirring for 10 min, vinylmagnesium bromide (6 mL 2
mol/L, 1.2 equiv) was slowly added to the mixture and stirred at the same temperature for 3 h.2 The reaction
was quenched with saturated aqueous NH4Cl. After filtration, the combined organic layers were dried over
Na2SO4 and concentrated under reduced pressure. The residue was purified by column chromatography on
silica gel (hexane/EtOAc=10:1) to provide 1-phenylprop-2-en-1-ol, 1.09g, 81% yield.
Step-2: To a solution of 1-phenylprop-2-en-1-ol (1.34g, 10 mmol ,1.0 equiv) in DMF (20 ml ) was removed
to a sealable reaction tube , Pd(OAc)2 (44.9 mg, 0.2 mmol, 0.02 equiv), X-PHOS (190.6 mg, 0.4 mmol, 0.04
equiv) , NaHCO3 (2.1 g, 24 mmol, 2.4 equiv) and methyl 2-bromobenzoate (2.14g, 10 mmol ,1.0 equiv) was
added. The tube was sealed with a Teflon-lined septum and heated to 120 oC with vigorous stirring for 16 h.
The resulting suspension was cooled to room temperature, diluted with EtOAc, and filtered through a pad of
Celite. The filtrate was concentrated in vacuo to afford the crude product, which was purified by flash
column chromatography on silica gel (hexane/EtOAc=10:1) to provide the key intermediate 3a-1 1.7g, 65%
yield, colorless oil; 1H NMR (300 MHz, Chloroform-d) δ 8.02 – 7.86 (m, 3H), 7.56 – 7.46 (m, 1H), 7.46 –
7.37 (m, 3H), 7.37 – 7.31 (m, 1H), 7.31 – 7.22 (m, 1H), 3.87 (s, 3H), 3.44 – 3.28 (m, 4H). 13
C NMR (75
MHz, CDCl3) δ 199.26, 167.72, 143.36, 136.88, 132.94, 132.27, 131.44, 130.87, 129.43, 128.52, 128.09,
126.32, 51.98, 40.56, 29.35; HRMS (TOF+) calcd for C17H17O3 [M+H]
+ 269.1099, found 269.1098.
Step-3: To a solution of 3a-1 (1.34g, 5.0 mmol, 1.0 equiv.) in acetic acid (15 mL) was added dilute
hydrochloric acid solution (5 ml 3mol/L, 3.0 equiv) and the mixture was then stirred for 12 h at 120oC. After
evaporation of acetic acid, water and EtOAc were added. The organic layer was washed with water, and
dried over magnesium sulfate. Concentration of the organic layer offered the crude product that was further
purified by flash column chromatography (hexane/EtOAc=6:1) to provide 3a-2 540 mg, 56% yield, white
solid; MP 89-91°C; 1H NMR (300 MHz, Chloroform-d) δ 10.23 (s, broad,1H), 8.14 – 8.08 (m, 1H), 8.06 –
10
7.96 (m, 2H), 7.57 – 7.30 (m, 6H), 3.52 – 3.44 (m, 2H), 3.43 – 3.35 (m, 2H). 13
C NMR (75 MHz, CDCl3) δ
199.74, 172.92, 144.26, 136.78, 133.29, 133.09, 131.92, 131.71, 130.20, 128.57, 128.20, 126.53, 40.57,
29.58; HRMS (TOF−) calcd for C16H13O3 [M−1]
−: 253.0943; found 253.0945..
Step-4: To a solution of 3a-2 (756 mg, 3.0 mmol, 1.0 equiv) in acetic acid ( 6 mL) was added piperidine
(0.1 mL, 1.2 mmol, 0.4 equiv) and formaldehyde solution (36.5-38% in H2O, 1mL, 13.2 mmol, 4.4 equiv) at
room temperature. The mixture was then stirred for 48 h at 90oC.
1 After evaporation of acetic acid, water
and EtOAc were added. The organic layer was washed with water, and dried over magnesium sulfate.
Concentration of the organic layer offered the crude product that was further purified by flash column
chromatography (hexane/EtOAc=6:1) to provide 3a 482 mg, 86%, white solid; MP 76-78°C; 1H NMR (300
MHz, Chloroform-d) δ 10.60 (s, broad, 1H), 8.16 – 8.05 (m, 1H), 7.86 – 7.74 (m, 2H), 7.61 – 7.47 (m, 2H),
7.46 – 7.32 (m, 4H), 5.65 (s, 1H), 5.52 (s, 1H), 4.22 (s, 2H). 13
C NMR (75 MHz, CDCl3) δ 198.22, 172.74,
147.71, 141.25, 137.56, 133.20, 132.34, 132.28, 131.97, 129.63, 128.72, 128.18, 126.88, 126.59, 36.54;
HRMS (TOF−) calcd for C17H13O3 [M−1]
−: 265.0870; found 265.0860.
654 mg, 89% yield, white solid; MP 126-128°C; 1H NMR (300 MHz, Chloroform-d) δ 10.03 (s, broad, 1H),
8.28 – 8.02 (m, 2H), 8.00 – 7.78 (m, 2H), 7.64 – 7.34 (m, 7H), 5.70 (s, 1H), 5.60 (s, 1H), 4.36 (s, 2H). 13
C
NMR (75 MHz, CDCl3) δ 199.41, 172.76, 149.67, 141.45, 136.49, 133.59, 133.27, 132.47, 132.09, 130.88,
130.84, 129.89, 128.74, 128.27, 127.21, 127.12, 126.94, 126.34, 125.55, 124.27, 35.61; HRMS (TOF−)
calcd for C21H15O3 [M−1] −
: 315.1027; found 315.1022.
482 mg, 87% yield, white solid; MP 91-93°C; 1H NMR (300 MHz, Chloroform-d) δ 9.21 (s, broad, 1H),
8.29 (s, 1H), 8.06 (d, J = 7.7 Hz, 1H), 8.00 – 7.76 (m, 4H), 7.61 – 7.29 (m, 5H), 5.69 (s, 1H), 5.53 (s, 1H),
4.26 (s, 2H). 13
C NMR (75 MHz, CDCl3) δ 198.19, 172.71, 147.94, 141.27, 135.23, 134.73, 133.19, 132.40,
132.24, 132.01, 131.39, 129.47, 128.76, 128.17, 128.14, 127.71, 126.89, 126.63, 126.09, 125.48, 36.79;
HRMS (TOF−) calcd for C21H15O3 [M−1]
−: 315.1027; found 315.1022.
462 mg, 91% yield, white solid; MP 92-94°C;1H NMR (300 MHz, Chloroform-d) δ 11.15 (s, broad, 1H),
8.14 (dd, J = 8.2, 1.5 Hz, 1H), 7.56 (td, J = 7.6, 1.4 Hz, 1H), 7.45 – 7.35 (m, 2H), 7.35 – 7.25 (m, 2H), 7.25
– 7.14 (m, 2H), 5.66 (s, 1H), 5.57 (s, 1H), 4.25 (s, 2H), 2.34 (s, 3H).13
C NMR (75 MHz, CDCl3) δ 200.06,
172.86, 149.08, 141.40, 138.80, 136.27, 133.19, 132.40, 132.00, 130.73, 129.85, 129.73, 128.78, 128.07,
126.87, 125.04, 35.26, 19.67; HRMS (TOF−) calcd for C18H15O3 [M−1]
−: 279.1027; found 279.1022.
11
454 mg, 89% yield, brown oil; 1H NMR (300 MHz, Chloroform-d) δ 9.12 (s, broad, 1H), 8.08 (d, J = 8.0 Hz,
1H), 7.64 – 7.46 (m, 3H), 7.44 – 7.23 (m, 4H), 5.65 (s, 1H), 5.52 (s, 1H), 4.21 (s, 2H), 2.38 (s, 3H). 13
C
NMR (75 MHz, CDCl3) δ 198.36, 172.61, 147.75, 141.25, 138.00, 137.63, 133.13, 133.02, 132.29, 131.91,
130.01, 128.80, 127.98, 126.91, 126.83, 126.51, 36.53, 21.32; HRMS (TOF−) calcd for C18H15O3 [M−1]
−:
279.1027; found 279.1022.
578 mg, 92% yield, white solid; MP 113-115°C; 1H NMR (300 MHz, Chloroform-d)
1H NMR (400 MHz,
Chloroform-d) δ 8.12 – 8.01 (m, 1H), 7.69 (d, J = 8.2 Hz, 2H), 7.53 (td, J = 7.7, 1.4 Hz, 1H), 7.42 – 7.33 (m,
2H), 7.21 (d, J = 7.9 Hz, 2H), 5.63 (s, 1H), 5.52 (s, 1H), 4.19 (s, 2H), 2.38 (s, 3H). 13
C NMR (75 MHz,
CDCl3) δ 197.89, 172.59, 147.73, 143.07, 141.20, 134.77, 133.09, 132.25, 131.88, 129.86, 128.87, 126.81,
125.74, 36.67, 21.56; HRMS (TOF−) calcd for C18H15O3 [M−1]
−: 279.1027; found 279.1022.
554 mg, 90% yield, white solid; MP 94-96°C; 1H NMR (300 MHz, Chloroform-d) δ 11.35 (s, broad, 1H),
8.21 – 8.10 (m, 1H), 7.61 – 7.51 (m, 1H), 7.45 – 7.26 (m, 4H), 7.25 – 7.14 (m, 2H), 5.66 (s, 1H), 5.58 (s,
1H), 4.26 (s, 2H), 2.34 (s, 3H). 13
C NMR (75 MHz, CDCl3) δ 200.08, 172.88, 149.10, 141.42, 138.80,
136.27, 133.21, 132.42, 132.02, 130.74, 129.87, 129.74, 128.78, 128.08, 126.88, 125.06, 35.27, 19.69;
HRMS (TOF−) calcd for C18H15O4 [M−1]
−: 295.0976; found 295.0974.
535 mg, 88% yield, white solid; MP 87-89°C; 1H NMR (300 MHz, Chloroform-d) δ 9.70 (s, broad, 1H),
8.08 (d, J = 8.0 Hz, 1H), 7.60 – 7.47 (m, 1H), 7.45 – 7.22 (m, 5H), 7.16 – 6.99 (m, 1H), 5.66 (s, 1H), 5.52 (s,
1H), 4.20 (s, 2H), 3.80 (s, 3H). 13
C NMR (75 MHz, CDCl3) δ 197.87, 172.61, 159.40, 147.66, 141.20,
138.86, 133.15, 132.31, 131.94, 129.13, 128.76, 126.86, 126.48, 122.33, 118.65, 113.99, 55.34, 36.57;
HRMS (TOF−) calcd for C18H15O4 [M−1]
−: 295.0976; found 295.0974.
564 mg, 92% yield, white solid; MP 121-123°C; 1H NMR (300 MHz, Chloroform-d) δ 10.65 (s, broad, 1H),
8.14 – 8.01 (m, 1H), 7.87 – 7.73 (m, 2H), 7.58 – 7.47 (m, 1H), 7.42 – 7.30 (m, 2H), 6.94 – 6.83 (m, 2H),
12
5.55 (s, 1H), 5.42 (s, 1H), 4.19 (s, 2H), 3.80 (s, 3H). 13
C NMR (75 MHz, CDCl3) δ 197.05, 172.67, 163.19,
147.78, 141.15, 133.12, 132.33, 132.12, 131.86, 129.90, 128.85, 126.83, 124.42, 113.47, 55.39, 36.96;
HRMS (TOF−) calcd for C18H15O4 [M−1]
−: 295.0976; found 295.0974.
589 mg, 88% yield, colorless oil; 1H NMR (400 MHz, Chloroform-d) δ 8.88 (s, 1H), 8.08 (dd, 1H), 7.52 (td,
J = 7.6, 1.2 Hz, 1H), 7.45 – 7.31 (m, 3H), 7.31 – 7.21 (m, 1H), 7.00 – 6.85 (m, 2H), 5.75 (s, 1H), 5.65 (s,
1H), 4.24 (s, 2H), 4.03 (q, J = 7.0 Hz, 2H), 1.33 (t, J = 7.0 Hz, 3H); 13
C NMR (100 MHz, CDCl3) δ 198.1,
172.5, 156.4, 148.6, 141.5, 132.8, 131.9, 131.7, 131.3, 129.3, 129.2, 129.0, 126.5, 120.2, 112.4, 64.1, 34.9,
14.6; HRMS (TOF−) calcd for C19H17O4 [M−1]
−: 309.1132; found 309.1130.
545 mg, 90% yield, white solid; MP 88-90°C; 1H NMR (300 MHz, Chloroform-d) δ 10.66 (s, broad, 1H),
8.09 (d, J = 7.7 Hz, 1H), 7.92 – 7.72 (m, 2H), 7.55 (t, J = 7.3 Hz, 1H), 7.37 (d, J = 6.8 Hz, 2H), 7.09 (td, J =
8.7, 2.2 Hz, 2H), 5.59 (s, 1H), 5.48 (s, 1H), 4.18 (s, 2H). 13
C NMR (75 MHz, CDCl3) δ 196.67, 172.72,
166.99 (d, J = 252.00 Hz), 147.73, 141.13, 133.69(d, J = 3.0 Hz), 133.29, 132.41(d, J = 9.8 Hz), 132.16(d, J
= 11.3 Hz), 128.55, 126.98, 125.75, 115.46, 115.17, 36.68; HRMS (TOF−) calcd for C17H12FO3 [M−1]
−:
283.0776; found 283.0780.
558 mg, 92% yield, white solid; MP 111-113°C; 1H NMR (300 MHz, Chloroform-d) δ 10.61 (s, broad, 1H),
8.15 – 8.05 (m, 1H), 7.78 – 7.66 (m, 2H), 7.62 – 7.48 (m, 1H), 7.42 – 7.32 (m, 4H), 5.60 (s, 1H), 5.49 (s,
1H), 4.18 (s, 2H). 13
C NMR (75 MHz, CDCl3) δ 196.83, 172.72, 147.65, 141.14, 138.68, 135.77, 133.30,
132.42, 132.06, 131.05, 128.51, 127.01, 126.18, 36.57; HRMS (TOF−) calcd for C17H12ClO3 [M−1]
−:
299.0480; found 299.0499.
545 mg, 85% yield, white solid; MP 107-109°C; 1H NMR (300 MHz, Chloroform-d) δ
1H NMR (400 MHz,
Chloroform-d) δ 8.10 (dd, J = 7.7, 1.1 Hz, 1H), 7.84 (d, J = 8.0 Hz, 2H), 7.68 (d, J = 8.1 Hz, 2H), 7.57 (td, J
= 7.5, 1.4 Hz, 1H), 7.47 – 7.34 (m, 2H), 5.64 (s, 1H), 5.56 (s, 1H), 4.19 (s, 2H).13
C NMR (75 MHz, CDCl3)
δ 196.83, 172.64, 147.70, 141.11, 140.71, 134.87, 133.40, 132.47, 132.14, 130.56, 129.74, 128.37, 127.32,
127.09, 125.21 (q, J = 3.8 Hz), 36.33; HRMS (TOF−) calcd for C18H12F3O3 [M−1]
−: 333.0744; found
333.0751.
13
745 mg, 83% yield, white solid; MP 120-124°C; 1H NMR (400 MHz, Chloroform-d) δ 8.06 (dd, J = 7.8, 1.2
Hz, 1H), 7.57 – 7.24 (m, 12H), 7.00 (d, J = 7.1 Hz, 1H), 5.58 (s, 1H), 5.37 (s, 1H), 4.04 (s, 2H). 13
C NMR
(100 MHz, CDCl3) δ 200.02, 172.51, 148.70, 141.10, 140.73, 139.09, 132.90, 132.17, 131.66, 130.13,
129.99, 129.86, 128.95, 128.88, 128.53, 128.46, 127.33, 126.98, 126.56, 34.76; HRMS (TOF−) calcd for
C23H17O3 [M−1] −
: 341.1183; found 341.1189.
346mg, 76% ,white solid; MP 106-108°C; 1H NMR (400 MHz, Chloroform-d) δ 9.86 (s, broad, 1H), 8.05 (d,
J = 7.8 Hz, 1H), 7.49 (t, J = 7.5 Hz, 1H), 7.34 (t, J = 7.6 Hz, 1H), 7.25 (d, J = 7.6 Hz, 1H), 6.03 (s, 1H), 5.42
(s, 1H), 4.01 (s, 2H), 3.03 (t, J = 10.8 Hz, 1H), 1.78 (d, J = 10.0 Hz, 4H), 1.69 (d, J = 11.7 Hz, 1H), 1.53 –
1.06 (m, 5H). 13
C NMR (100 MHz, CDCl3) δ 205.43, 172.54, 147.43, 141.47, 132.84, 131.87, 131.71,
128.99, 126.60, 124.02, 45.10, 35.55, 29.51, 25.89, 25.80 ; HRMS (TOF−) calcd for C17H13O3 [M−1]
−:
271.0870; found 271.0860.
503 mg, 84% yield, white solid; MP 88-90°C; 1H NMR (300 MHz, Chloroform-d) δ 10.23 (s, broad, 1H),
8.15 – 8.00 (m, 1H), 7.71 – 7.58 (m, 2H), 7.57 – 7.47 (m, 1H), 7.41 – 7.30 (m, 2H), 7.07 (dd, J = 4.9, 3.8 Hz,
1H), 5.82 (s, 1H), 5.41 (s, 1H), 4.18 (s, 2H). 13
C NMR (75 MHz, CDCl3) δ 189.65, 172.67, 147.91, 143.15,
140.90, 134.26, 134.14, 133.17, 132.25, 131.91, 128.76, 127.88, 126.91, 123.85, 36.88; HRMS (TOF−)
calcd for C15H12O3S [M−1]−: 271.0434; found 271.0428.
545 mg, 89% yield, white solid; MP 105-107°C;
1H NMR (300 MHz, Chloroform-d) δ 7.92 (d, J = 7.1 Hz,
1H), 7.84 – 7.77 (m, 2H), 7.58 – 7.49 (m, 1H), 7.48 – 7.39 (m, 3H), 7.29 (t, J = 7.7 Hz, 1H), 5.59 (s, 1H),
5.26 (s, 1H), 4.18 (s, 2H), 2.40 (s, 3H). 13
C NMR (75 MHz, CDCl3) δ 198.42, 146.60, 138.90, 137.67,
135.00, 132.26, 129.66, 129.46, 128.19, 126.59, 125.38, 32.33, 19.90; HRMS (TOF−) calcd for C18H15O3
[M−1] −
: 279.1027; found 279.1022.
14
531 mg, 84% yield, white solid; MP 106-108°C; 1H NMR (300 MHz, Chloroform-d) δ
1H NMR (400 MHz,
Chloroform-d) δ 9.58 (s, broad, 1H), 8.09 – 7.95 (m, 1H), 7.85 – 7.69 (m, 2H), 7.55 – 7.48 (m, 1H), 7.45 –
7.36 (m, 2H), 7.24 – 7.03 (m, 2H), 5.62 (s, 1H), 5.50 (s, 1H), 4.17 (s, 2H), 2.41 (s, 3H). 13
C NMR (75 MHz,
CDCl3) δ 198.29, 172.66, 147.88, 144.03, 141.43, 137.64, 133.23, 132.24, 129.65, 128.17, 127.66, 126.31,
125.75, 36.59, 21.57; HRMS (TOF−) calcd for C18H15O3 [M−1]
−: 279.1027; found 279.1022.
532 mg, 85% yield, white solid; MP 112-114°C; 1H NMR (300 MHz, Chloroform-d)
1H NMR (400 MHz,
Chloroform-d) δ 9.58 (s, broad, 1H), 8.09 – 7.95 (m, 1H), 7.85 – 7.69 (m, 2H), 7.55 – 7.48 (m, 1H), 7.45 –
7.36 (m, 2H), 7.24 – 7.03 (m, 2H), 5.62 (s, 1H), 5.50 (s, 1H), 4.17 (s, 2H), 2.41 (s, 3H). 13
C NMR (75 MHz,
CDCl3) δ 198.27, 172.99, 147.90, 138.13, 137.64, 136.59, 133.98, 132.43, 132.30, 132.22, 129.65, 128.51,
128.17, 126.47, 36.19, 20.88; HRMS (TOF−) calcd for C18H15O3 [M−1]
−: 279.1027; found 279.1022.
545 mg, 83% yield, white solid; MP 119-121°C; 1H NMR (400 MHz, Chloroform-d) δ 7.89 (s, broad, 1H),
7.42 – 7.31 (m, 2H), 7.30 – 7.23 (m, 2H), 7.02 – 6.87 (m, 2H), 5.69 (s, 1H), 5.59 (s, 1H), 4.17 (s, 2H), 3.78
(s, 3H), 2.40 (s, 3H). 13
C NMR (100 MHz, CDCl3) δ 198.03, 172.67, 157.15, 148.99, 138.24, 136.30, 133.67,
132.14, 132.07, 131.39, 129.21, 128.97, 128.82, 120.19, 111.39, 55.64, 34.70, 20.84; HRMS (TOF−) calcd
for C19H17O4 [M−1]−: 309.1132; found 309.1130.
SYNTHESIS OF BROMOLACTONE PRODUCTS
General Procedure for Bromolactonization. To a PhMe/CHCl3 (4 mL/1 ml) solution of α, β-unsaturated
ketone (0.1 mmol, 1.0 equiv) and catalyst (7.1 mg, 0.15 mmol, 0.15 equiv), at 15oC, in dark under nitrogen
was added halogen source (0.13 mmol, 1.3 equiv). The resulting mixture was stirred at 15oC and monitored
by TLC. The reaction was quenched with saturated Na2SO3 (1 mL) at 15oC and then was warm to room
temperature. The solution was diluted with water (3 mL) and extrated with EtOAc, dried over MgSO4 and
concentrated in vacuo. The residue was purified by flash column chromatography (hexane/EtOAc=3:1) to
yield the corresponding lactone.
15
34.0 mg, 98% yield, white solid; MP 109-111°C; []
D25= 34.5 (c 1.0, MeOH, 15:85 er);
1H NMR (300 MHz,
Chloroform-d) 1H NMR (400 MHz, Chloroform-d) δ 8.06 – 7.96 (m, 2H), 7.90 – 7.80 (m, 1H), 7.61 – 7.50
(m, 2H), 7.47 – 7.38 (m, 2H), 7.32 (t, J = 7.2 Hz, 2H), 4.05 (d, J = 11.1 Hz, 1H), 3.84 (d, J = 11.1 Hz, 1H),
3.76 (d, J = 16.1 Hz, 1H), 3.50 (d, J = 16.0 Hz, 1H). 13
C NMR (75 MHz, CDCl3) δ 197.55, 162.84, 136.78,
134.58, 134.51, 133.53, 130.07, 129.88, 128.58, 128.03, 127.99, 124.00, 88.81, 35.09, 34.65; HRMS (TOF+)
calcd. for C17H14BrO3 [M+H]+ 345.0048, found 345.0053; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane
= 10/90, 1.0 mL/min, 254 nm) t1 = 18.4 min (minor), t2 = 19.4 min (major).
38.6 mg, 97% yield, white solid; MP 98-100°C; []
D25= –17.7 (c 1.0, MeOH, 14:86 er);
1H NMR (300 MHz,
Chloroform-d) δ 8.12 (dd, J = 7.3, 1.0 Hz, 1H), 7.93 (d, J = 8.2 Hz, 1H), 7.77 (d, J = 8.2 Hz, 1H), 7.57 –
7.42 (m, 3H), 7.42 – 7.35 (m, 1H), 7.34 – 7.17 (m, 3H), 7.09 (t, J = 7.6 Hz, 1H), 4.21 (d, J = 11.1 Hz, 1H),
3.96 (d, J = 11.2 Hz, 1H), 3.74 (d, J = 15.9 Hz, 1H), 3.61 (d, J = 15.9 Hz, 1H). 13
C NMR (75 MHz, CDCl3)
δ 202.44, 163.00, 135.40, 134.42, 133.50, 132.56, 129.86, 129.72, 128.36, 128.19, 127.97, 127.70, 127.38,
126.12, 124.91, 124.02, 88.90, 36.06, 35.44; HRMS (TOF+) calcd. for C21H16BrO3 [M+H]
+ 395.0277, found
395.0280; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane = 10/90, 2.0 mL/min, 254 nm) t1 = 7.9 min
(minor), t2 = 11.0 min (major).
16
39.0 mg, 98% yield, colorless oil; []
D25= 30.5 (c 1.0, MeOH, 21:79 er);
1H NMR (300 MHz, Chloroform-d)
1H NMR (400 MHz, Chloroform-d) δ 8.77 (s, 1H), 8.02 (d, J = 8.1 Hz, 1H), 7.94 (dd, J = 8.7, 1.8 Hz, 1H),
7.89 – 7.76 (m, 3H), 7.71 – 7.50 (m, 3H), 7.39 – 7.23 (m, 2H), 4.14 (d, J = 11.2 Hz, 1H), 3.92 (d, J = 11.2
Hz, 1H), 3.84 (d, J = 16.0 Hz, 1H), 3.55 (d, J = 16.0 Hz, 1H). 13
C NMR (100 MHz, CDCl3) δ 197.10, 162.94,
136.99, 135.51, 134.65, 132.52, 132.27, 131.53, 130.19, 130.17, 129.18, 128.42, 128.03, 127.62, 126.95,
125.07, 123.89, 89.10, 35.39, 34.70 HRMS (TOF+) calcd. for C21H16BrO3 [M+H]
+ 395.0277, found
395.0280 ; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane = 10/90, 2.0 mL/min, 254 nm) t1 = 7.5 min
(minor), t2 = 9.7 min (major).
17
35.8 mg, 99% yield, white solid; MP 91-93°C; []
D25= –7.5 (c 1.0, MeOH, 11:89 er);
1H NMR (300 MHz,
Chloroform-d) δ 7.83 (dd, J = 7.5, 1.5 Hz, 1H), 7.72 (d, J = 7.1 Hz, 1H), 7.54 (td, J = 7.5, 1.3 Hz, 1H), 7.37
– 7.25 (m, 4H), 7.04 (d, J = 7.0 Hz, 1H), 4.12 (d, J = 11.2 Hz, 1H), 3.89 (d, J = 11.2 Hz, 1H), 3.67 – 3.50 (m,
2H), 1.67 (s, 3H). 13
C NMR (75 MHz, CDCl3) δ 203.14, 162.81, 137.93, 135.69, 134.93, 134.37, 131.50,
131.22, 129.81, 128.66, 128.32, 127.80, 125.19, 124.97, 88.74, 35.89, 35.53, 19.04; HRMS (TOF+) calcd.
for C18H16BrO3 [M+H] +
359.0277, found 359.0278; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane =
10/90, 1.0 mL/min, 254 nm) t1 = 9.3 min (minor), t2 = 10.9 min (major).
35.6 mg, 99% yield, white solid; MP 118-120°C; []
D25= 6.5 (c 1.0, MeOH, 18:82 er);
1H NMR (300 MHz,
Chloroform-d) δ 7.86 (d, J = 7.1 Hz, 2H), 7.75 (s, 1H), 7.61 – 7.50 (m, 1H), 7.40 – 7.27 (m, 4H), 4.05 (d, J
= 11.1 Hz, 1H), 3.91 – 3.66 (m, 2H), 3.50 (d, J = 16.0 Hz, 1H), 2.38 (s, 3H). 13
C NMR (75 MHz, CDCl3) δ
197.56, 162.85, 138.44, 136.87, 134.52, 134.46, 134.36, 130.25, 130.08, 128.44, 127.97, 127.10, 124.03,
88.80, 35.18, 34.62, 21.33; HRMS (TOF+) calcd. for C18H16BrO3 [M+H]
+ 359.0277, found 359.0278;
18
HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane = 10/90, 1.0 mL/min, 254 nm) t1 = 8.5 min (minor), t2 =
10.1 min (major).
35.3 mg, 98% yield, colorless oil; []
D25= 25.5 (c 1.0, MeOH, 17:83 er);
1H NMR (400 MHz, Chloroform-d)
δ 7.98 – 7.93 (m, 2H), 7.87 (dd, J = 8.0, 1.2 Hz, 1H), 7.55 (td, J = 7.6, 1.3 Hz, 1H), 7.32 (t, J = 7.0 Hz, 2H),
7.22 (d, J = 8.1 Hz, 2H), 4.05 (d, J = 11.1 Hz, 1H), 3.88 – 3.72 (m, 2H), 3.50 (d, J = 16.0 Hz, 1H), 2.39 (s,
3H). 13
C NMR (101 MHz, CDCl3) δ 196.68, 162.95, 144.75, 137.05, 134.54, 131.75, 130.19, 130.10, 129.33,
128.00, 127.94, 123.92, 88.86, 35.29, 34.56, 21.70; HRMS (TOF+) calcd. for C18H16BrO3 [M+H]
+ 359.0277,
found 359.0278; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane = 10/90, 1.0 mL/min, 254 nm) t1 = 11.6
min (minor), t2 = 13.8 min (major).
19
37.2 mg, 99% yield, white solid; MP 112-114°C; []
D25= 42.0 (c 1.0, MeOH, 10:90 er);
1H NMR (400 MHz,
Chloroform-d) δ 7.83 (dd, J = 7.7, 1.4 Hz, 1H), 7.75 – 7.69 (m, 1H), 7.54 (td, J = 7.5, 1.3 Hz, 1H), 7.37 –
7.22 (m, 5H), 7.04 (d, J = 7.5 Hz, 1H), 4.11 (d, J = 11.2 Hz, 1H), 3.88 (d, J = 11.2 Hz, 1H), 3.67 – 3.50 (m,
2H), 1.67 (s, 3H). 13
C NMR (100 MHz, CDCl3) δ 203.05, 162.74, 137.92, 135.71, 134.98, 134.33, 131.46,
131.21, 129.81, 128.64, 128.28, 127.78, 125.18, 124.99, 88.70, 35.85, 35.50, 19.04; HRMS (TOF+) calcd.
for C18H16BrO4 [M+H] +
375.0154, found 375.0152; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane =
10/90, 1.0 mL/min, 254 nm) t1 = 9.2 min (minor), t2 = 10.8 min (major).
37.1 mg, 99% yield, colorless oil; []
D25= 6.8 (c 1.0, MeOH, 19:81 er);
1H NMR (300 MHz, Chloroform-d) δ
7.87 (d, J = 7.8 Hz, 1H), 7.68 (d, J = 7.9 Hz, 1H), 7.56 (td, J = 7.6, 1.3 Hz, 1H), 7.49 – 7.43 (m, 1H), 7.38 –
7.27 (m, 3H), 7.10 (dd, J = 7.9, 3.0 Hz, 1H), 4.05 (d, J = 11.1 Hz, 1H), 3.84 (d, J = 12.7 Hz, 4H), 3.76 (d, J
= 16.0 Hz, 1H), 3.49 (d, J = 16.0 Hz, 1H). 13
C NMR (75 MHz, CDCl3) δ 197.19, 162.86, 159.49, 136.79,
135.52, 134.59, 130.13, 129.64, 128.05, 127.97, 123.97, 122.47, 120.36, 114.14, 88.84, 55.45, 35.19, 34.73;
20
HRMS (TOF+) calcd. for C18H16BrO4 [M+H]
+ 375.0154, found 375.0152; HPLC (Daicel Chiralpak AD-H,
i-PrOH/Hexane = 10/90, 1.0 mL/min, 254 nm) t1 = 12.8 min (minor), t2 = 13.7 min (major).
37.0 mg, 99% yield, colorless oil; []
D25= 50.7 (c 1.0, MeOH, 14:86 er);
1H NMR (300 MHz, Chloroform-d)
δ 8.16 – 8.06 (m, 2H), 7.87 (dd, J = 8.0, 1.1 Hz, 1H), 7.54 (td, J = 7.6, 1.3 Hz, 1H), 7.35 – 7.27 (m, 2H),
6.94 – 6.85 (m, 2H), 4.05 (d, J = 11.2 Hz, 1H), 3.86 (s, 3H), 3.85 – 3.73 (m, 2H), 3.49 (d, J = 16.0 Hz, 1H).
13C NMR (75 MHz, CDCl3) δ 195.01, 163.94, 163.09, 137.31, 134.59, 132.84, 130.10, 128.03, 127.90,
126.95, 123.79, 113.90, 88.98, 55.51, 35.55, 34.51; HRMS (TOF+) calcd. for C18H16BrO4 [M+H]
+ 375.0154,
found 375.0152; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane = 10/90, 1.0 mL/min, 254 nm) t1 = 16.9
min (minor), t2 = 21.2 min (major).
21
36.9 mg, 95% yield, white solid; MP 123-125°C; []
D25= 25.3 (c 1.0, MeOH, 80:20 er);
1H NMR (400 MHz,
Chloroform-d) δ 7.79 – 7.72 (m, 1H), 7.55 (td, J = 7.5, 1.3 Hz, 1H), 7.40 – 7.30 (m, 2H), 7.26 (d, J = 7.6 Hz,
1H), 6.89 (dd, J = 8.5, 0.8 Hz, 1H), 6.78 (td, J = 7.5, 0.9 Hz, 1H), 6.61 (dd, J = 7.6, 1.7 Hz, 1H), 4.34 (d, J =
11.3 Hz, 1H), 4.23 – 4.01 (m, 2H), 3.84 (d, J = 11.3 Hz, 1H), 3.70 – 3.54 (m, 2H), 1.41 (t, J = 7.0 Hz, 3H).
13C NMR (100 MHz, CDCl3) δ 204.57, 162.85, 156.27, 135.95, 134.10, 133.01, 129.71, 128.73, 127.94,
127.90, 127.63, 124.97, 120.44, 112.04, 88.19, 64.48, 35.95, 34.84, 14.64; HRMS (TOF+) calcd. for
C19H18BrO4 [M+H] +
389.0383, found 389.0381; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane = 10/90,
2.0 mL/min, 254 nm) t1 = 4.9 min (major), t2 = 6.6 min (minor).
34.4 mg, 95% yield, colorless oil; []
D25= 32.3 (c 1.0, MeOH, 16:84 er);
1H NMR (400 MHz, Chloroform-d)
δ 8.10 (dd, J = 8.8, 5.5 Hz, 2H), 7.86 (d, J = 7.7 Hz, 1H), 7.55 (t, J = 7.5 Hz, 1H), 7.32 (t, J = 8.8 Hz, 2H),
7.09 (t, J = 8.6 Hz, 2H), 4.02 (d, J = 11.1 Hz, 1H), 3.85 – 3.69 (m, 2H), 3.47 (d, J = 16.0 Hz, 1H).13
C NMR
(100 MHz, Chloroform-d) δ 195.95 , 165.82 (d, J = 257.1 Hz), 162.71 , 136.78 , 134.69 , 133.02 (d, J = 9.5
Hz), 130.79 (d, J = 3.3 Hz), 130.14 , 128.10 , 128.02 , 123.82 , 115.85 (d, J = 21.8 Hz), 88.83 , 34.98 ,
22
34.64 ; HRMS (TOF+) calcd. for C17H13BrFO3 [M+H]
+ 363.0003, found 363.0001; HPLC (Daicel Chiralpak
AD-H, i-PrOH/Hexane = 10/90, 2.0 mL/min, 254 nm) t1 = 6.4 min (minor), t2 = 8.6 min (major).
36.7 mg, 97% yield, white solid; MP 111-113°C; []
D25= 50.4 (c 1.0, MeOH, 16:84 er);
1H NMR (400 MHz,
Chloroform-d) δ 8.02 – 7.96 (m, 2H), 7.86 (d, J = 7.8 Hz, 1H), 7.55 (td, J = 7.6, 1.2 Hz, 1H), 7.42 – 7.36 (m,
2H), 7.36 – 7.29 (m, 2H), 4.00 (d, J = 11.1 Hz, 1H), 3.84 – 3.69 (m, 2H), 3.47 (d, J = 16.1 Hz, 1H). 13
C
NMR (100 MHz, CDCl3) δ 196.48, 162.62, 140.26, 136.67, 134.70, 132.76, 131.48, 130.18, 128.95, 128.14,
128.01, 123.83, 88.79, 34.86, 34.63; HRMS (TOF+) calcd. for C17H13BrClO3 [M+H]
+ 378.9731, found
378.9735; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane = 10/90, 2.0 mL/min, 254 nm) t1 = 6.7 min
(minor), t2 = 8.9 min (major).
23
40.3 mg, 98% yield, white solid; MP 88-90°C; []
D25= 18.5 (c 1.0, MeOH, 19:81 er);
1H NMR (400 MHz,
Chloroform-d) δ 8.11 (d, J = 8.2 Hz, 2H), 7.89 – 7.83 (m, 1H), 7.69 (d, J = 8.3 Hz, 2H), 7.58 (td, J = 7.6, 1.3
Hz, 1H), 7.39 – 7.30 (m, 2H), 4.01 (d, J = 11.1 Hz, 1H), 3.85 – 3.70 (m, 2H), 3.48 (d, J = 16.1 Hz, 1H). 13
C
NMR (100 MHz, CDCl3) δ 197.34, 162.44, 137.48, 136.33, 134.80, 134.75, 134.42, 130.22, 128.29, 128.01,
125.61 (q, J = 303 Hz), 123.86, 88.69, 34.67, 34.51; HRMS (TOF+) calcd. for C18H13BrF3O3 [M+H]
+
412.9995, found 412.9996; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane = 10/90, 2.0 mL/min, 254 nm)
t1 = 9.3 min (minor), t2 = 12.3 min (major).
42.0 mg, 99% yield, white solid; MP 131-133°C; []
D25= 7.5 (c 1.0, MeOH, 12:88 er);
1H NMR (400 MHz,
Chloroform-d) δ 7.79 – 7.72 (m, 1H), 7.56 (td, J = 7.5, 1.3 Hz, 1H), 7.46 (td, J = 7.6, 1.3 Hz, 1H), 7.40 –
7.28 (m, 5H), 7.24 – 7.16 (m, 2H), 7.11 (d, J = 9.5 Hz, 2H), 6.94 – 6.85 (m, 1H), 3.58 – 3.42 (m, 2H), 3.22
(d, J = 16.2 Hz, 1H), 3.03 (d, J = 11.4 Hz, 1H). 13
C NMR (100 MHz, CDCl3) δ 205.68, 162.28, 140.98,
140.59, 136.89, 135.77, 134.26, 130.89, 130.16, 129.88, 129.55, 128.35, 128.08, 127.94, 127.90, 127.71,
126.82, 124.91, 88.23, 36.19, 35.24; HRMS (TOF+) calcd. for C23H18BrO3 [M+H]
+ 421.0434, found
24
421.0439; HPLC (Daicel Chiralcel AD-H, i-PrOH/Hexane = 10/90, 2.0 mL/min, 254 nm) t1 = 4.3 min
(minor), t2 = 5.7 min (major).
4o
33.1 mg, 95%, colorless oil; MP 119-121°C; []
D25= 14.5 (c 1.0, MeOH, 36:64 er);
1H NMR (400 MHz,
Chloroform-d) δ 8.10 (d, J = 7.8 Hz, 1H), 7.57 (td, J = 7.5, 1.3 Hz, 1H), 7.42 (t, J = 7.6 Hz, 1H), 7.26 (d, J =
7.6 Hz, 1H), 3.76 (d, J = 11.1 Hz, 1H), 3.58 (d, J = 11.1 Hz, 1H), 3.46 (d, J = 16.5 Hz, 1H), 3.33 (d, J = 16.5
Hz, 1H), 3.12 – 2.94 (m, 1H), 1.94 – 1.74 (m, 2H), 1.71 – 1.63 (m, 2H), 1.49 – 1.05 (m, 6H). 13
C NMR (100
MHz, CDCl3) δ 210.78, 162.94, 136.16, 134.60, 130.28, 128.24, 128.00, 124.02, 87.60, 45.42, 34.29, 33.41,
28.95, 28.78, 25.52, 25.35; HRMS (TOF+) calcd. for C17H14BrO3 [M+H]+ 351.0048, found 351.0053;
HPLC (Daicel Chiralcel AD-H, i-PrOH/Hexane = 5/95, 1.0 mL/min, 254 nm) t1 = 10.2 min (minor), t2 =
10.8 min (major).
25
34,2 mg, 98% yield, white solid; MP 124-126°C; []
D25= 27.5 (c 1.0, MeOH, 25:75 er);
1H NMR (300 MHz,
Chloroform-d) δ 8.31 (dd, J = 4.0, 1.0 Hz, 1H), 7.98 (d, J = 7.2 Hz, 1H), 7.73 (dd, J = 5.0, 1.0 Hz, 1H), 7.58
(td, J = 7.5, 1.3 Hz, 1H), 7.42 – 7.30 (m, 2H), 7.19 (dd, J = 4.9, 4.0 Hz, 1H), 3.99 (d, J = 11.2 Hz, 1H), 3.85
– 3.73 (m, 2H), 3.52 (d, J = 16.2 Hz, 1H). 13
C NMR (100 MHz, CDCl3) δ 188.80, 162.86, 139.73, 137.08,
136.44, 136.35, 134.75, 130.38, 128.94, 128.14, 128.04, 123.57, 87.99, 35.50, 33.55; HRMS (TOF+) calcd.
for C15H11BrO3S [M+H]+ 350.9685, found 350.9667; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane =
10/90, 2.0 mL/min, 254 nm) t1 = 9.3 min (minor), t2 = 12.3 min (major).
35.1 mg, 98% yield, white solid; MP 130-132°C; []
D25= 25.5 (c 1.0, MeOH, 13:87 er);
1H NMR (300 MHz,
Chloroform-d) δ 8.07 – 7.97 (m, 2H), 7.72 (d, J = 7.6 Hz, 1H), 7.61 – 7.52 (m, 1H), 7.43 (t, J = 7.7 Hz, 3H),
7.21 (t, J = 7.7 Hz, 1H), 4.06 (d, J = 11.1 Hz, 1H), 3.90 – 3.74 (m, 2H), 3.32 (d, J = 16.3 Hz, 1H), 2.40 (s,
3H). 13
C NMR (75 MHz, CDCl3) δ 197.54, 163.28, 135.94, 135.91, 135.48, 134.38, 133.60, 129.95, 128.62,
127.90, 127.39, 123.92, 88.43, 35.24, 31.50, 18.98; HRMS (TOF+) calcd. for C18H16BrO3 [M+H]
+ 359.0277,
found 359.0278; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane = 10/90, 1.0 mL/min, 254 nm) t1 = 10.6
min (minor), t2 = 11.8 min (major).
26
35.8 mg, 99% yield, white solid; MP 113-115°C; []
D25= 29.5 (c 1.0, MeOH, 86:14 er);
1H NMR (300 MHz,
Chloroform-d) δ 8.08 – 7.96 (m, 2H), 7.74 (d, J = 8.4 Hz, 1H), 7.62 – 7.48 (m, 1H), 7.48 – 7.36 (m, 2H),
7.11 (d, J = 5.6 Hz, 2H), 4.04 (d, J = 11.1 Hz, 1H), 3.82 (d, J = 11.1 Hz, 1H), 3.71 (d, J = 16.0 Hz, 1H), 3.44
(d, J = 16.0 Hz, 1H), 2.40 (s, 3H). 13
C NMR (75 MHz, CDCl3) δ 197.61, 162.99, 145.85, 136.85, 134.45,
133.56, 130.15, 129.96, 128.98, 128.58, 128.50, 121.23, 88.73, 35.16, 34.55, 21.86; HRMS (TOF+) calcd.
for C18H16BrO3 [M+H]+ 359.0277, found 359.0278; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane =
10/90, 1.0 mL/min, 254 nm) t1 = 18.2 min (minor), t2 = 21.1 min (major).
27
35.5 mg, 99% yield, white solid; MP 114-116°C; []
D25= 26.8 (c 1.0, MeOH, 14:86 er);
1H NMR (300 MHz,
Chloroform-d) δ 8.06 – 7.97 (m, 2H), 7.67 (s, 1H), 7.59 – 7.51 (m, 1H), 7.42 (t, J = 7.6 Hz, 2H), 7.38 – 7.32
(m, 1H), 7.19 (d, J = 7.8 Hz, 1H), 4.04 (d, J = 11.1 Hz, 1H), 3.83 (d, J = 11.1 Hz, 1H), 3.72 (d, J = 16.0 Hz,
1H), 3.44 (d, J = 16.0 Hz, 1H), 2.32 (s, 3H). 13
C NMR (75 MHz, CDCl3) δ 197.60, 163.17, 138.01, 135.56,
134.47, 133.76, 133.55, 130.29, 129.94, 128.58, 127.87, 123.65, 88.86, 35.13, 34.27, 20.95; HRMS (TOF+)
calcd. for C18H16BrO3 [M+H]+ 359.0277, found 359.0278; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane
= 10/90, 1.0 mL/min, 254 nm) t1 = 5.1 min (minor), t2 = 5.8 min (major).
38.4 mg, 99% yield, white solid; MP 122-124°C; []
D25= 67.8 (c 1.0, MeOH, 30:70 er);
1H NMR (400 MHz,
Chloroform-d) δ 7.62 (s, 1H), 7.44 – 7.33 (m, 2H), 7.16 (d, J = 7.7 Hz, 1H), 6.87 (dd, J = 16.9, 7.9 Hz, 2H),
6.80 (dd, J = 7.6, 1.8 Hz, 1H), 4.18 (d, J = 11.2 Hz, 1H), 3.81 (d, J = 11.2 Hz, 1H), 3.77 (s, 3H), 3.63 – 3.48
(m, 2H), 2.36 (s, 3H).13
C NMR (100 MHz, CDCl3) δ 203.93, 163.11, 156.63, 137.88, 134.98, 132.93,
132.80, 129.86, 128.51, 127.81, 127.42, 124.61, 120.58, 111.38, 88.16, 55.78, 35.76, 34.25, 20.94; HRMS
(TOF+) calcd. for C19H18BrO4 [M+H]
+ 389.0383, found 389.0381; HPLC (Daicel Chiralpak AD-H,
i-PrOH/Hexane = 10/90, 2.0 mL/min, 254 nm) t1 = 8.1 min (minor), t2 = 10.1 min (major).
28
Synthetic Application.
To a solution of 4g (37mg, 0.1 mmol, 1.0 equiv) in DMF ( 3 mL) was added NaN3 (19.5 mg, 0.3 mmol, 3 equiv), The
mixture was then stirred for 4 h at 60oC. The solution was diluted with water (1.5 mL) and extrated with EtOAc, dried over
MgSO4 and concentrated in vacuo. The residue was purified by flash column chromatography (hexane/EtOAc=10:1) to
yield the corresponding azide derivative 7 32.0 mg, 99% yield, white solid; MP 91-93°C; []
D25= 9.8 (c 1.0, MeOH,
10:90 er); 1H NMR (400 MHz, Chloroform-d) δ 7.77 – 7.67 (m, 2H), 7.53 (td, J = 7.5, 1.2 Hz, 1H), 7.37 –
7.23 (m, 4H), 7.03 (d, J = 7.0 Hz, 1H), 4.12 (d, J = 12.9 Hz, 1H), 3.85 (d, J = 12.9 Hz, 1H), 3.57 – 3.38 (m,
2H), 1.58 (s, 3H). 13
C NMR (100 MHz, CDCl3) δ 204.72, 162.63, 137.48, 135.62, 135.41, 134.27, 131.30,
131.08, 129.85, 128.43, 128.31, 127.78, 125.17, 125.15, 89.70, 56.92, 34.23, 18.65; HRMS (TOF+) calcd.
for C18H16N3O4 [M+H]+ 337.10063, found 337.1060; HPLC (Daicel Chiralpak AD-H, i-PrOH/Hexane =
10/90, 1.0 mL/min, 254 nm) t1 = 5.9 min (minor), t2 = 6.9 min (major).
29
To a solution of 4g (37mg, 0.1 mmol, 1.0 equiv) in EtOH ( 3 mL) was added NaHCO3 (17 mg, 0.2 mmol, 2
equiv), The mixture was then stirred for overnight at 70oC. The solution was diluted with water (1.5 mL)
and extrated with EtOAc, dried over MgSO4 and concentrated in vacuo. The residue was purified by flash
column chromatography (hexane/EtOAc=10:1) to yield the corresponding chiral ether derivative 8 32.3 mg,
95% yield, colorless oil; []
D25= 12.3 (c 1.0, MeOH, 10:90 er);1H NMR (400 MHz, Chloroform-d) δ 7.89 (dd,
J = 7.8, 1.1 Hz, 1H), 7.49 – 7.41 (m, 2H), 7.38 – 7.30 (m, 3H), 7.20 (t, J = 6.9 Hz, 2H), 4.37 (q, J = 7.1 Hz,
2H), 4.05 (d, J = 14.6 Hz, 1H), 3.79 (d, J = 14.7 Hz, 1H), 2.70 (d, J = 5.2 Hz, 1H), 2.57 (d, J = 5.2 Hz, 1H),
2.31 (s, 3H), 1.41 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 203.43, 167.60, 137.36, 136.13,
135.52, 132.40, 131.57, 131.51, 130.83, 130.68, 130.36, 128.10, 127.01, 124.94, 62.39, 60.94, 49.76, 33.20,
19.79, 14.28; HRMS (TOF+) calcd. for C20H21O5 [M+H]
+ 341.1131, found 341.1129; HPLC (Daicel
Chiralpak AD-H, i-PrOH/Hexane = 10/90, 1.0 mL/min, 254 nm) t1 = 5.9 min (minor), t2 = 6.9 min (major).
X-ray of 4b
30
References
1. Tay, D. W.; Jong, H.; Lim, Y. H.; Wu, W.; Chew, X.; Robins, E. G.; Johannes, C. W. J. Org. Chem. 2015, 80, 4054.
2. Jiang, X.; Liu, S.; Yang, S.; Jing, M.; X, L.; Yu, P.; Wang, Y.; Yeung, Y.-Y. Org. Lett. 2018, 20, 3259.
31
1H/
13C Spectra
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
top related